Hyperprolactinemia: Clinical Trials

1 trial for Hyperprolactinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Cabergoline (Dopamine Agonist) - Prolactinoma
Phase 4RecruitingUniversity Hospital, Basel, Switzerland602025-09-162025-09-23

Narrower conditions

Prolactin Deficiency, Isolated (1)  ·  Prolactinoma (1)

Broader conditions

Adenoma (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Hyperpituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Nervous System Diseases (1)  ·  Pituitary Diseases (1)  ·  Pituitary Neoplasms (1)

Interventions

Cabergoline (1)  ·  Dopamine Agonists (1)

Sponsors

University Hospital, Basel, Switzerland (1)

Countries

Switzerland (1)

Top investigators

Cihan Atila, Dr. (1)

NIH funding

2025 (1)